Your shopping cart is empty
Subscriber login
REGISTER FOR FREE EZINES
Advanced Search
- Please Select -
Regulation
Business Development
Drug Manufacturing
Device Manufacturing
Quality Management
Home
Books
Conferences
DVDs
Newsletters
Form 483
s
Pharma Quality Advisor
Webinar Training Pass
White Papers
Advertising/Sponsorships
About Us
Check out our free and informative ezines and sign up now
Sign Up
Home
>
Newsletters
>
FDAnews Drug Daily Bulletin
> India Revokes Roche Patent
FDAnews Drug Daily Bulletin
Nov. 6, 2012
| Vol. 9 No. 218
India Revokes Roche Patent
In the latest blow to multinational drug companies, a government board in India has revoked the patent of Roche Holding AG’s expensive drug for an infectious liver disease.
The Wall Street Journal
Register Now
Print This Page
Email This Article
RSS
Archives
Related Articles
Full Issue
Correction
Astellas Scraps EU Marketing Plans for Kidney Cancer Candidate
Merck Ends Trials For Once-Promising Parkinson’s Drug